Our Privacy Statement & Cookie Policy

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

Lung Cancer Awareness Month: Early detection and more precise treatment offer new hope

Yuan Xiaoqian

VCG
VCG

VCG

November is Lung Cancer Awareness Month. According to the latest estimates released by the International Agency for Research on Cancer (IARC) in 2026, there were approximately 2.6 million new lung cancer cases and 1.9 million related deaths worldwide in 2024, ranking first among all cancers in both incidence and mortality.

However, the outlook for people diagnosed with lung cancer is improving. According to the National Cancer Center of China, the age-standardized five-year relative survival rate for lung cancer rose from 18.7% in 2008–2010 to 32.1% in 2019–2021. Early detection and timely treatment are key factors behind this improvement.

Active smoking remains the leading risk factor for lung cancer, but several other exposures also raise risk, including secondhand smoke, cooking fumes, indoor and outdoor air pollution, and hazardous substances in the workplace.

Early detection

Early-stage lung cancer often causes few noticeable or specific symptoms. Lung tissue itself is relatively insensitive to pain, and the lungs can compensate for some loss of function. People should seek medical attention if a cough persists for more than two to three weeks, an existing cough worsens, or symptoms such as blood in the sputum, chest pain or shortness of breath occur. These symptoms do not necessarily indicate lung cancer, but should not be dismissed.

Appropriate screening is crucial for early detection. Chest X-rays can miss small lesions and cannot replace recommended screening. China's National Health Commission recommends low-dose computed tomography (LDCT) for people at high risk of lung cancer.

People aged 50 or older are considered high-risk if they have at least one of the following backgrounds: a smoking history of 20 pack-years (a measure of the total amount a person has smoked over their lifetime) or more; at least 20 years of living or working in the same room as a smoker; chronic obstructive pulmonary disease; relevant occupational exposure; or a first-degree relative diagnosed with lung cancer. For high-risk individuals without a history of lung cancer, generally those aged 50 to 74, annual LDCT screening is recommended.

A pulmonary nodule does not necessarily mean cancer. Studies show that at least 95% of pulmonary nodules are benign. Their size, appearance and changes over time should guide follow-up or further examinations under medical advice.

Precise treatment

Minimally invasive surgery and precision medicine are expanding treatment options. For eligible patients with early-stage disease, video-assisted thoracoscopic and robot-assisted surgery can reduce surgical trauma, speed up recovery and help preserve healthy lung tissue.

For advanced lung cancer, genetic testing, targeted therapy and immunotherapy are making treatment more personalized. Doctors can identify tumor driver mutations and consider PD-L1 expression and other biomarkers, along with tumor type and the patient's overall health when developing a treatment plan. Some patients with advanced disease can achieve long-term disease control and a better quality of life through appropriate treatment.

Alongside these medical advances, public awareness is equally important: reducing exposure to tobacco and other harmful substances, ensuring high-risk groups receive recommended screening, paying attention to unusual symptoms and avoiding unnecessary anxiety over pulmonary nodules.

Prevention, early detection and appropriate treatment remain key to tackling lung cancer.

Search Trends